Filing Details
- Accession Number:
- 0001209191-19-029148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-10 20:10:02
- Reporting Period:
- 2019-05-08
- Accepted Time:
- 2019-05-10 20:10:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649689 | J James Vaughn | 301 Penobscot Drive Redwood City CA 94063 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-08 | 3,000 | $31.12 | 26,164 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-08 | 1,500 | $31.12 | 27,664 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-08 | 600 | $57.08 | 27,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 1,258 | $57.89 | 25,806 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 1,142 | $58.91 | 24,664 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 358 | $57.15 | 24,306 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 542 | $57.73 | 23,764 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 600 | $58.86 | 23,164 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 700 | $57.15 | 22,464 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 1,044 | $57.82 | 21,420 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-08 | 1,000 | $58.94 | 20,420 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-05-08 | 3,000 | $0.00 | 3,000 | $31.12 |
| Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-05-08 | 1,500 | $0.00 | 1,500 | $31.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,897 | 2025-02-13 | No | 4 | M | Direct | |
| 15,397 | 2025-02-13 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 11,281 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 6, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $56.57 to $57.53.
- Represents weighted average sale price. Actual sale prices ranged from $57.65 to $58.60.
- Represents weighted average sale price. Actual sale prices ranged from $58.65 to $59.44.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 11, 2019.
- Represents weighted average sale price. Actual sale prices ranged from $56.55 to $57.53.
- Represents weighted average sale price. Actual sale prices ranged from $57.58 to $57.98.
- Represents weighted average sale price. Actual sale prices ranged from $58.61 to $59.20.
- Represents weighted average sale price. Actual sale prices ranged from $56.57 to $57.54.
- Represents weighted average sale price. Actual sale prices ranged from $57.60 to $58.26.
- Represents weighted average sale price. Actual sale prices ranged from $58.60 to $59.44.
- The option became exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
